Clinical Trial Update: Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intranasal dexmedetomidine for pain management during screening for retinopathy of prematurity is currently recruiting. Spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinopathy of Prematurity

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Retinopathy of Prematurity, Dexmedetomidine | Phase 3 | Status: RECRUITING